Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinically relevant anti-epileptic drug interactions.

F Pisani1, E Perucca, R Di Perri

  • 1First Neurological Clinic, University of Messina, Italy.

The Journal of International Medical Research
|January 1, 1990
PubMed
Summary

Anti-epileptic drug interactions are common due to metabolism changes and drug combinations. These interactions can increase toxicity or reduce medication effectiveness, impacting patient treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.

Acta neurologica Scandinavica·2017
Same author

Influence of cytotoxic T-lymphocyte antigen-4 polymorphisms on acute rejection onset of cadaveric renal transplants.

Transplantation proceedings·2013
Same author

For anti-HLA-specific donor antibodies detection by flow cytometry cytotoxic crossmatches comparison of methods.

Transplantation proceedings·2013
Same author

Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis.

Neuroscience·2012
Same author

Cytomegalovirus and gastric cancer after renal transplantation: a possible interplay.

Transplantation proceedings·2012
Same author

Management of kidney transplantation in a factor VII-deficient patient: case report.

Transplantation proceedings·2012

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Neuroscience

Background:

  • Anti-epileptic drugs (AEDs) often undergo interactions due to pharmacokinetic properties like metabolism induction/inhibition and low therapeutic indices.
  • Prolonged treatment and polypharmacy for comorbidities increase the likelihood of drug-drug interactions in epilepsy management.

Purpose of the Study:

  • To review the pharmacokinetic and pharmacodynamic interactions of anti-epileptic drugs.
  • To highlight interactions that increase AED toxicity or reduce the efficacy of co-administered medications.

Main Methods:

  • Literature review of pharmacokinetic and pharmacodynamic interactions involving common anti-epileptic drugs.
  • Analysis of drug metabolism pathways (CYP450 induction/inhibition) and their clinical implications.

Main Results:

  • Key interactions involve inhibition of phenytoin, carbamazepine, and phenobarbitone metabolism, leading to increased toxicity. Examples include macrolides, chloramphenicol, and valproic acid.
  • AEDs can induce hepatic enzymes, reducing the efficacy of corticosteroids, oral contraceptives, anticoagulants, and other drugs.
  • Beneficial pharmacodynamic interactions include synergism between ethosuximide and valproic acid, and carbamazepine and valproic acid.

Conclusions:

  • Understanding AED interactions is crucial for optimizing epilepsy treatment and preventing adverse events.
  • Clinicians must consider potential drug-drug interactions when prescribing AEDs, especially in patients with comorbidities or on polypharmacy.

Related Experiment Videos